Stay updated on Clinical Trial of IL-2 + Nivolumab in RCC

Sign up to get notified when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial of IL-2 + Nivolumab in RCC page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a technical or platform release rather than a change to the displayed clinical trial details.
    Difference
    0.1%
    Check dated 2026-04-24T05:45:34.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:13:10.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:00:41.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; this change seems to be a software version update and does not modify the study details or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-03-12T02:32:08.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the broad government funding operating-status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:22:55.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    New government funding notice banner now appears at the top of the page. The page revision tag was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:26:25.000Z thumbnail image

Stay in the know with updates to Clinical Trial of IL-2 + Nivolumab in RCC

Enter your email address, and we'll notify you when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.